Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mills, G. D
Right arrow Articles by Sears, M. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mills, G. D
Right arrow Articles by Sears, M. R
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology 2000;29:280-284
© International Epidemiological Association 2000

Chlamydia pneumoniae serological status is not associated with asthma in children or young adults

Graham D Millsa, Jennifer A Lindemanb, J Paul Fawcettc, G Peter Herbisond and Malcolm R Searse

a Waikato Academic Division, School of Medicine, University of Auckland, Hamilton, New Zealand.
b Waikato Hospital, Hamilton, New Zealand.
c School of Pharmacy, University of Otago, Dunedin, New Zealand.
d Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand.
e Asthma Research Group, McMaster University, Hamilton, Ontario, Canada.

Reprint requests to: Dr Graham Mills, Waikato Academic Division, School of Medicine, Bryant Education Centre, Waikato Hospital, Private Bag 3200, Hamilton, New Zealand. E-mail: millsg{at}hwl.co.nz

Background The factors that cause the allergic sensitization and inflammation in asthma still remain to be clarified. A role for Chlamydia pneumoniae has been suggested although serological studies have produced conflicting findings. This study aims to clarify the relationship between asthmatic variables and C. pneumoniae serological status.

Methods A case-control study was undertaken on an asthma-enriched subset from a longitudinal birth cohort. In all, 198 subjects (96 with self-reported asthma) had C. pneumoniae serology (microimmunofluorescence [MIF] IgG, IgA) undertaken at age 11 and age 21 and assessment made in relation to a number of asthma variables.

Results The only statistically significant finding was in subjects self-reporting asthma at age 21 who had evidence of lower IgG titres (P = 0.046), a finding in the opposite direction to that expected from the hypothesis. Subjects with high IgG titres (>=128) were less likely to have reported ever having asthma; odds ratio (OR) = 0.29, (95% CI : 0.10–0.87). No association existed between symptoms suggestive of asthma in the previous 12 months and either IgG (P = 0.127) or IgA (P = 0.189) antibody titres at age 21. Likewise, no association was found between symptoms suggestive of asthma in the previous two years and C. pneumoniae IgG antibody titre (P = 0.81) at age 11. There was no evidence of an association with any of the other variables examined at either age 11 or age 21. These included use of inhaled steroids, serum IgE levels, airway responsiveness, skin test evidence of atopy, or smoking status.

Conclusion The results of this study suggest that C. pneumoniae infection when diagnosed by MIF serology is not a major risk factor for the development of asthma in children and young adults. The study has not, however, addressed the role this organism may play in specific asthmatic subsets or asthma exacerbations.

Keywords Asthma, Chlamydia pneumoniae, serology, adolescence, child

Accepted 19 August 1999


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
ThoraxHome page
E Normann, J Gnarpe, B Wettergren, C Janson, M Wickman, and L Nordvall
Association between Chlamydia pneumoniae antibodies and wheezing in young children and the influence of sex
Thorax, December 1, 2006; 61(12): 1054 - 1058.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. L. Johnston and R. J. Martin
Chlamydophila pneumoniae and Mycoplasma pneumoniae: A Role in Asthma Pathogenesis?
Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1078 - 1089.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
N Teig, A Anders, C Schmidt, C Rieger, and S Gatermann
Chlamydophilapneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases
Thorax, November 1, 2005; 60(11): 962 - 966.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
G Dal Molin, B Longo, T Not, A Poli, and C Campello
A population based seroepidemiological survey of Chlamydia pneumoniae infections in schoolchildren
J. Clin. Pathol., June 1, 2005; 58(6): 617 - 620.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. F. Lemanske Jr.
Is Asthma an Infectious Disease?: Thomas A. Neff Lecture
Chest, March 1, 2003; 123(2007): 385S - 390S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. N. BLACK, F. BLASI, C. R. JENKINS, R. SCICCHITANO, G. D. MILLS, A. R. RUBINFELD, R. E. RUFFIN, P. R. MULLINS, J. DANGAIN, B. C. COOPER, et al.
Trial of Roxithromycin in Subjects with Asthma and Serological Evidence of Infection with Chlamydia pneumoniae
Am. J. Respir. Crit. Care Med., August 15, 2001; 164(4): 536 - 541.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.